Ursodeoxycholic Acid

• Recruiting NCT NCT02961413

  A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）

  Drug Induced Liver Disease Study Group 10000 participants Est. completion 2030-12 1 site
  Other conditions: Drug-induced Liver Injury
  View official trial listing →
• Recruiting NCT NCT04650243

  Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

  Not yet reported Peking Union Medical College Hospital 90 participants Est. completion 2025-05 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT04924868

  Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis

  Not yet reported Hospital General Universitario de Alicante 332 participants Est. completion 2027-07-01 18 sites
  Other conditions: Acute Pancreatitis Due to Gallstones
  View official trial listing →
• Recruiting NCT NCT05749822

  Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

  Not yet reported, Not yet reported Xijing Hospital of Digestive Diseases 104 participants Est. completion 2027-12-31 12 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT05751967

  Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

  Not yet reported Xijing Hospital of Digestive Diseases 150 participants Est. completion 2027-12-01 7 sites Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT05925309

  Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy

  Not yet reported Children's Hospital of Fudan University 356 participants Est. completion 2029-12-31 1 site Stand-alone
  Other conditions: Biliary Atresia, Cholangitis, Anti-Bacterial Agents
  View official trial listing →
• Recruiting NCT NCT06294847

  Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery

  Not yet reported Hopital Foch 120 participants Est. completion 2027-11 2 sites Stand-alone
  Other conditions: Retinal Detachment
  View official trial listing →
• Recruiting NCT NCT06365424

  Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

  Not yet reported, Not yet reported Xijing Hospital of Digestive Diseases 117 participants Est. completion 2027-04 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT06443606

  Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy

  Not yet reported Assistance Publique - Hôpitaux de Paris 108 participants Est. completion 2029-06-01 1 site
  Other conditions: BPC, Non Optimal Response to UDCA
  View official trial listing →
• Recruiting NCT NCT06610760

  Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia

  Not yet reported Yongquan Shi 196 participants Est. completion 2026-10-31 6 sites Stand-alone
  Other conditions: Gastric Intestinal Metaplasia
  View official trial listing →
• Recruiting NCT NCT06684106

  Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

  Not yet reported First Affiliated Hospital Xi'an Jiaotong University 128 participants Est. completion 2027-06-01 2 sites Stand-alone
  Other conditions: Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
  View official trial listing →
• Recruiting NCT NCT06755151

  Fenofibrate in Primary Biliary Cholangitis: a Real World Study

  Not yet reported Xijing Hospital of Digestive Diseases 300 participants Est. completion 2035-12 1 site
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Recruiting NCT NCT06755541

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

  Not yet reported Xijing Hospital of Digestive Diseases 150 participants Est. completion 2035-12 1 site Stand-alone
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Recruiting NCT NCT06864481

  Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

  University Hospital, Montpellier 250 participants Est. completion 2028-04-22 1 site
  Other conditions: Liver Injury, Secondary to Immune Checkpoint Inhibitors, Cancer Patients
  View official trial listing →
• Recruiting NCT NCT06922669

  Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia

  Not yet reported General Hospital of Shenyang Military Region 232 participants Est. completion 2027-09-30 1 site Stand-alone
  Other conditions: Drug Induced Liver Injury
  View official trial listing →
• Recruiting NCT NCT07005752

  A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

  Not yet reported Myungmoon Pharma. Co. Ltd. 484 participants Est. completion 2028-06-13 13 sites Stand-alone
  Other conditions: Cholesterol Cholelithiasis
  View official trial listing →
• Recruiting NCT NCT07068191

  Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

  Not yet reported Phenomen Pharma 90 participants Est. completion 2025-08 1 site
  MASLD Other conditions: Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly, Nonalcoholic Fatty Liver (NAFL), Fatty Liver, Fatty Liver, Alcoholic, Fatty Liver, Nonalcoholic, Fatty Liver Disease
  View official trial listing →
• Recruiting NCT NCT07110987

  The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia

  Not yet reported Tishreen University Hospital 70 participants Est. completion 2027-03-01 1 site Stand-alone
  Other conditions: Hyperbilirubinemia, Neonatal Indirect
  View official trial listing →
• Recruiting NCT NCT07282353

  A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

  Not yet reported Cascade Pharmaceuticals, Inc 135 participants Est. completion 2028-01-06 42 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT07296458

  FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

  Not yet reported Xijing Hospital of Digestive Diseases 132 participants Est. completion 2028-12-31 1 site
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Recruiting NCT NCT07378761

  Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis

  Not yet reported University Hospital, Montpellier 94 participants Est. completion 2028-12 6 sites Stand-alone
  Other conditions: Immune-Mediated Cholestasis
  View official trial listing →
• Recruiting NCT NCT07424677

  Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy

  Not yet reported Zydus Therapeutics Inc. 90 participants Est. completion 2028-11 1 site
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Recruiting NCT NCT07672860

  Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors

  Not yet reported Jinling Hospital, China 162 participants Est. completion 2027-12 1 site Stand-alone
  Other conditions: Kidney Cancer
  View official trial listing →
• Recruiting NCT NCT07717242

  Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

  Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80 participants Est. completion 2029-01-31 1 site Stand-alone
  Other conditions: Bladder Urothelial Carcinoma, Bladder Cancer
  View official trial listing →
• Recruiting NCT NCT07889999

  Clinical Profile of Patients With MASLD in Kazakhstan and Clinical Effectiveness of Ursosan in Almaty

  Kazakh Association of Internal Medicine Specialists 420 participants Est. completion 2028-08-12 7 sites
  MASLD
  View official trial listing →
• Status unknown NCT NCT00004315

  Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease

  Not yet reported National Center for Research Resources (NCRR) 20 participants 1 site
  Other conditions: Cystic Fibrosis, Gastrointestinal Diseases, Cholestasis
  View official trial listing →
• Completed NCT NCT00004441

  Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

  Not yet reported Children's Hospital Medical Center, Cincinnati 39 participants Est. completion 2001-09 3 sites
  Other conditions: Cystic Fibrosis
  View official trial listing →
• Terminated NCT NCT00004442

  Study of Bile Acids in Patients With Peroxisomal Disorders

  Not yet reported University of Cincinnati 25 participants Est. completion 1999-04
  Other conditions: Infantile Refsum's Disease, Zellweger Syndrome, Bifunctional Enzyme Deficiency, Adrenoleukodystrophy
  View official trial listing →
• Completed NCT NCT00004748

  Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis

  Not yet reported National Center for Research Resources (NCRR) 90 participants
  Other conditions: Liver Cirrhosis, Biliary
  View official trial listing →
• Completed NCT NCT00004784

  Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis

  Not yet reported National Center for Research Resources (NCRR) 315 participants
  Other conditions: Liver Cirrhosis, Biliary
  View official trial listing →
• Completed NCT NCT00006168

  Ursodiol-Methotrexate for Primary Biliary Cirrhosis

  Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Est. completion 2004-03 12 sites
  Other conditions: Liver Cirrhosis, Biliary
  View official trial listing →
• Terminated NCT NCT00042549

  Lithotripsy for the Treatment of Gallstones

  Not yet reported Medstone International 184 participants 2 sites
  Other conditions: Cholelithiasis
  View official trial listing →
• Terminated NCT NCT00059202

  Trial of High-dose Urso in Primary Sclerosing Cholangitis

  Not yet reported, Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 150 participants Est. completion 2008-06 7 sites Stand-alone
  Other conditions: Primary Sclerosing Cholangitis
  View official trial listing →
• Terminated NCT NCT00062023

  Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

  Not yet reported M.D. Anderson Cancer Center 12 participants Est. completion 2006-05 1 site
  Other conditions: Colorectal Cancer
  View official trial listing →
• Status unknown NCT NCT00134758

  Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

  Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 90 participants Est. completion 2009-10 1 site Stand-alone
  Other conditions: Adenomatous Polyposis Coli, Familial
  View official trial listing →
• Completed NCT NCT00161083

  UDCA for Symptomatic Gallstone Disease

  Not yet reported UMC Utrecht 180 participants Est. completion 2004-11 1 site
  Other conditions: Cholecystolithiasis
  View official trial listing →
• Completed NCT NCT00200343

  Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

  Not yet reported Tanabe Pharma Corporation 596 participants Est. completion 2004-12 1 site Stand-alone
  Other conditions: Chronic Hepatitis C
  View official trial listing →
• Status unknown NCT NCT00285597

  Ursodeoxycholic Acid in Chronic Heart Failure

  Not yet reported National Heart and Lung Institute Est. completion 2006-01 1 site
  Heart failure
  View official trial listing →
• Terminated NCT NCT00414869

  Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure

  Not yet reported Forest Laboratories 11 participants Est. completion 2007-02 1 site
  Other conditions: Portal Hypertension
  View official trial listing →
• Status unknown NCT NCT00514774

  Ursodiol in Huntington's Disease

  Not yet reported Oregon Health and Science University 21 participants Est. completion 2009-06 1 site
  Other conditions: Huntington Disease
  View official trial listing →
• Terminated NCT NCT00550862

  Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)

  Not yet reported Intercept Pharmaceuticals 165 participants Est. completion 2010-12 32 sites Stand-alone
  Other conditions: Liver Cirrhosis, Biliary
  View official trial listing →
• Withdrawn NCT NCT00587119

  Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis

  Not yet reported Mayo Clinic Est. completion 2009-07
  Other conditions: Primary Biliary Cirrhosis, Autoimmune Hepatitis
  View official trial listing →
• Completed NCT NCT00588302

  Moexipril for Primary Biliary Cirrhosis

  Not yet reported Mayo Clinic 20 participants Est. completion 2007-06 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT00706381

  Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

  Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31 participants Est. completion 2012-08-21 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Terminated NCT NCT00746486

  Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)

  Not yet reported Dr. Falk Pharma GmbH 62 participants Est. completion 2019-10 2 sites Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT00805805

  Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis

  Not yet reported George Brewer 29 participants Est. completion 2008-12 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT00808743

  Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis

  Not yet reported, Not yet reported Radboud University Medical Center 37 participants Est. completion 2013-01 5 sites Stand-alone
  Other conditions: Familial Adenomatous Polyposis, Duodenal Neoplasms, Duodenal Polyps
  View official trial listing →
• Completed NCT NCT00846963

  Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates

  Not yet reported, Not yet reported Ibrahim Mohamed 26 participants Est. completion 2013-03 1 site
  Other conditions: Cholestasis
  View official trial listing →
• Completed NCT NCT00857480

  Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

  Not yet reported Norgine 12 participants Est. completion 2006-10 1 site Stand-alone
  Other conditions: Hepatic Cirrhosis
  View official trial listing →
• Completed NCT NCT00858858

  Clinical Studies on Bile Acids in Barrett's Esophagus

  Not yet reported US Department of Veterans Affairs 60 participants Est. completion 2015-02 1 site Stand-alone
  Other conditions: Gastroesophageal Reflux Disease
  View official trial listing →
• Completed NCT NCT00873275

  Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

  Not yet reported City of Hope Medical Center 11 participants Est. completion 2025-02-26 1 site
  Other conditions: Colorectal Cancer
  View official trial listing →
• Completed NCT NCT00877604

  Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis

  Not yet reported Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 34 participants Est. completion 2012-04 1 site
  Other conditions: Amyotrophic Lateral Sclerosis
  View official trial listing →
• Completed NCT NCT00909610

  Ursodiol Tablets 500 mg Under Fasting Conditions

  Not yet reported Teva Pharmaceuticals USA 80 participants Est. completion 2007-01 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00909753

  Ursodiol 500 mg Tablets Under Fed Conditions

  Not yet reported Teva Pharmaceuticals USA 92 participants Est. completion 2006-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00990639

  Effect of Candesartan in Alcoholic Liver Fibrosis

  Not yet reported, Not yet reported Yonsei University 85 participants Est. completion 2009-03 1 site Stand-alone
  Other conditions: Alcoholic Liver Disease
  View official trial listing →
• Completed NCT NCT01073202

  Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation

  Not yet reported Shanghai Jiao Tong University School of Medicine 112 participants Est. completion 2009-01 1 site
  Other conditions: Liver Transplantation, Ischemia-reperfusion Injury, Cholestasis
  View official trial listing →
• Completed NCT NCT01088607

  Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis

  Not yet reported University of Tennessee 27 participants Est. completion 2017-06 12 sites Stand-alone
  Other conditions: Primary Sclerosing Cholangitis
  View official trial listing →
• Completed NCT NCT01097304

  Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

  Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2014-07 4 sites
  Other conditions: Barrett Esophagus, Esophageal Carcinoma
  View official trial listing →
• Withdrawn NCT NCT01141296

  Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

  Not yet reported University of Miami 2 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT01141322

  Cholestatic Drug-induced Liver Injury

  Not yet reported Taipei Veterans General Hospital, Taiwan 180 participants Est. completion 2010-07 1 site Stand-alone
  Other conditions: Hepatitis, Toxic
  View official trial listing →
• Completed NCT NCT01149304

  Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity

  Not yet reported University of Magdeburg 22 participants 1 site Stand-alone
  Other conditions: Colorectal Cancer, Liver Metastases, Irradiation Damage, Radiation Induced Liver Disease
  View official trial listing →
• Status unknown NCT NCT01157780

  Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation

  Not yet reported University of Tennessee 100 participants Est. completion 2014-12 1 site
  Other conditions: Parenteral Nutrition Associated Liver Disease
  View official trial listing →
• Withdrawn NCT NCT01226823

  Ursodeoxycholic Acid And Cholestasis Of Pregnancy

  Not yet reported University of Bologna Est. completion 2013-11 7 sites Stand-alone
  Other conditions: Intrahepatic Cholestasis of Pregnancy
  View official trial listing →
• Status unknown NCT NCT01337440

  Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases

  Not yet reported Kanazawa University 20 participants Est. completion 2013-03 1 site
  Type 2 diabetes Other conditions: Chronic Liver Disease
  View official trial listing →
• Completed NCT NCT01389973

  A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid

  Not yet reported Janssen Research & Development, LLC 20 participants Est. completion 2013-06 10 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Terminated NCT NCT01430429

  Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody

  Not yet reported Light Chain Bioscience - Novimmune SA 2 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT01440309

  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis

  Not yet reported Robert Chunhua Zhao, MD, PhD 20 participants Est. completion 2013-12 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT01456468

  Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

  Not yet reported Yale University 19 participants Est. completion 2015-12 2 sites
  Other conditions: Cholangitis, Sclerosing
  View official trial listing →
• Status unknown NCT NCT01483248

  Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis

  Not yet reported, Not yet reported S-Evans Biosciences Co., Ltd. 50 participants Est. completion 2015-10 1 site
  Other conditions: Liver Cirrhosis, Fibrosis, Liver Disease, Digestive System Disease
  View official trial listing →
• Completed NCT NCT01505569

  Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

  Not yet reported Masonic Cancer Center, University of Minnesota 44 participants Est. completion 2024-02-01 1 site
  Obstructive sleep apnea Other conditions: Ewing's Family Tumors, Renal Tumors, Hepatoblastoma, Soft Tissue Sarcoma, Primary Malignant Brain Neoplasms, Retinoblastoma, Medulloblastoma, Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET), Atypical Teratoid/Rhabdoid Tumor (AT/RT), CNS Tumors, Germ Cell Tumors
  View official trial listing →
• Completed NCT NCT01510860

  Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

  Not yet reported Dr. Falk Pharma GmbH 65 participants Est. completion 2010-07 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT01548079

  Ursodeoxycholic Acid in Bariatric Surgery

  Not yet reported Sahlgrenska University Hospital 40 participants Est. completion 2010-05
  Other conditions: Non-alcoholic Fatty Liver Disease, Morbid Obesity
  View official trial listing →
• Completed NCT NCT01576458

  Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy

  Not yet reported Turku University Hospital 20 participants Est. completion 1998-12 1 site
  Other conditions: Intrahepatic Cholestasis, Pregnancy
  View official trial listing →
• Completed NCT NCT01654731

  Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

  Not yet reported Assistance Publique - Hôpitaux de Paris 100 participants Est. completion 2016-12-31 1 site
  Other conditions: PBC
  View official trial listing →
• Status unknown NCT NCT01688375

  The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice

  Not yet reported University Clinical Centre of Kosova 54 participants Est. completion 2013-12 3 sites Stand-alone
  Other conditions: Obstructive Jaundice
  View official trial listing →
• Completed NCT NCT01764204

  Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

  China Academy of Chinese Medical Sciences 30840 participants Est. completion 2018-01 48 sites
  Other conditions: Adverse Drug Events, Adverse Drug Reactions
  View official trial listing →
• Completed NCT NCT01829698

  Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC

  Not yet reported Beijing Trendful Kangjian Medical Information Consulting Limited Company 199 participants Est. completion 2014-02 1 site
  Other conditions: Cholestatic Liver Disease
  View official trial listing →
• Completed NCT NCT01857284

  Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis

  Not yet reported Beijing Friendship Hospital 216 participants Est. completion 2013-01 25 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT01865812

  Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

  Not yet reported Intercept Pharmaceuticals 27 participants Est. completion 2016-09-12 7 sites Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT01899703

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

  Not yet reported GlaxoSmithKline 22 participants Est. completion 2015-10-07 3 sites Stand-alone
  Other conditions: Cholestasis, Intrahepatic
  View official trial listing →
• Completed NCT NCT01904058

  Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

  Not yet reported Mirum Pharmaceuticals, Inc. 66 participants Est. completion 2015-04 24 sites Stand-alone
  Other conditions: PBC, Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT01965990

  VLCD by Enteral Route for Weight Loss

  San Giuseppe Moscati Hospital 364 participants Est. completion 2013-02 1 site
  Other conditions: Severe Obesity
  View official trial listing →
• Completed NCT NCT01974336

  The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients

  Not yet reported Jinling Hospital, China 30 participants Est. completion 2016-09 1 site Stand-alone
  Other conditions: Short Bowel Syndrome
  View official trial listing →
• Completed NCT NCT02016365

  Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis

  Not yet reported Umeå University 55 participants Est. completion 2014-12 3 sites Stand-alone
  Other conditions: Transthyretin Amyloidosis, Cardiomyopathy
  View official trial listing →
• Completed NCT NCT02021110

  Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease

  Not yet reported Radboud University Medical Center 34 participants Est. completion 2015-10 3 sites Stand-alone
  Other conditions: Polycystic Liver Disease, Polycystic Kidney, Autosomal Dominant
  View official trial listing →
• Completed NCT NCT02026401

  Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

  Not yet reported NGM Biopharmaceuticals, Inc 45 participants Est. completion 2014-12 17 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT02033876

  Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin

  Not yet reported Mayo Clinic 24 participants Est. completion 2017-03 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02078882

  Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

  Not yet reported Christopher Bowlus, MD 16 participants Est. completion 2018-10 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Terminated NCT NCT02244944

  Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

  Not yet reported Gregory Graf, PhD 2 participants Est. completion 2015-09 1 site
  MASLD
  View official trial listing →
• Status unknown NCT NCT02319629

  Preventive Therapy With Ursodiol to Reduce the Incidence of Gallstones Formation in Patients After Bariatric Surgery

  Not yet reported HaEmek Medical Center, Israel 266 participants Est. completion 2018-12 1 site Stand-alone
  Other conditions: Morbid Obesity
  View official trial listing →
• Status unknown NCT NCT02338635

  Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis

  Not yet reported Ewha Womans University 55 participants Est. completion 2018-01 Stand-alone
  Other conditions: End-Stage Kidney Disease
  View official trial listing →
• Completed NCT NCT02340247

  Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass

  Not yet reported Hvidovre University Hospital 11 participants 1 site Stand-alone
  Other conditions: Severe Obesity
  View official trial listing →
• Completed NCT NCT02385032

  Comparative Bioavailability Study of UDCA

  Not yet reported Daewoong Pharmaceutical Co. LTD. 50 participants Est. completion 2015-05
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02415777

  Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

  Not yet reported Daewoong Pharmaceutical Co. LTD. 168 participants Est. completion 2015-07 1 site Stand-alone
  Other conditions: Fatigue
  View official trial listing →
• Completed NCT NCT02418130

  A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.

  Not yet reported Daewoong Pharmaceutical Co. LTD. 166 participants Est. completion 2015-03 1 site Stand-alone
  Other conditions: Fatigue
  View official trial listing →
• Withdrawn NCT NCT02420496

  Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

  Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2016-06 1 site
  Other conditions: Cholestasis, Liver Disease
  View official trial listing →
• Terminated NCT NCT02472509

  The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders

  Not yet reported Shaare Zedek Medical Center 3 participants Est. completion 2017-09-10 1 site Stand-alone
  Other conditions: Hemolytic Disorders, Gallstones
  View official trial listing →
• Terminated NCT NCT02609048

  Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC)

  Not yet reported Gilead Sciences 41 participants Est. completion 2016-07-01 49 sites
  Other conditions: Primary Biliary Cirrhosis (PBC)
  View official trial listing →
• Completed NCT NCT02622685

  A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

  Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2016-02 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02651350

  Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI

  Not yet reported, Not yet reported Beijing 302 Hospital 80 participants Est. completion 2019-07 1 site Stand-alone
  Other conditions: Drug-induced Liver Injury,Chronic
  View official trial listing →
• Status unknown NCT NCT02721862

  Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy

  Not yet reported American University of Beirut Medical Center 100 participants Est. completion 2019-03 2 sites Stand-alone
  Other conditions: Cholelithiasis
  View official trial listing →
• Completed NCT NCT02748616

  C. Difficile and Ursodiol

  Not yet reported NYU Langone Health 9 participants Est. completion 2020-01-31 1 site
  Other conditions: Diarrhea
  View official trial listing →
• Status unknown NCT NCT02789644

  Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Elderly After UDCA Administration

  Not yet reported Seoul National University Hospital 16 participants Est. completion 2016-07 1 site Stand-alone
  Other conditions: Aged
  View official trial listing →
• Completed NCT NCT02823353

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

  Not yet reported Xijing Hospital of Digestive Diseases 117 participants Est. completion 2022-06 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT02823366

  Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

  Not yet reported Xijing Hospital of Digestive Diseases 104 participants Est. completion 2023-12 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT02841306

  Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment

  Not yet reported Francine Behar-Cohen 26 participants Est. completion 2017-09 1 site
  Other conditions: Rhegmatogenous Retinal Detachment
  View official trial listing →
• Status unknown NCT NCT02916290

  Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

  Not yet reported Xijing Hospital of Digestive Diseases 200 participants 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT02916641

  Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid

  Not yet reported Xijing Hospital of Digestive Diseases 200 participants 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT02936596

  Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

  Not yet reported Xiaoli Fan 53 participants Est. completion 2022-06-01 1 site Stand-alone
  Other conditions: Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary, Cholestasis
  View official trial listing →
• Status unknown NCT NCT02937012

  Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

  Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 34 participants Est. completion 2019-12 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT02943707

  Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.

  Not yet reported Wenzhou Medical University 40 participants Est. completion 2020-10 1 site Stand-alone
  Other conditions: Liver Diseases
  View official trial listing →
• Completed NCT NCT02955602

  Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

  Not yet reported Gilead Sciences 119 participants Est. completion 2019-07-08 38 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Withdrawn NCT NCT02965911

  Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

  Not yet reported, Not yet reported Beijing 302 Hospital Est. completion 2021-09-08 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT02967250

  Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment

  Not yet reported University of Minnesota 5 participants Est. completion 2022-02-28 1 site Stand-alone
  Other conditions: Parkinson Disease
  View official trial listing →
• Status unknown NCT NCT03000218

  Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems

  Not yet reported Seoul National University Hospital 30 participants 1 site Stand-alone
  Other conditions: Overweight, Abnormal Liver Function Tests
  View official trial listing →
• Status unknown NCT NCT03004118

  Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia

  Not yet reported Universitaire Ziekenhuizen KU Leuven 16 participants Est. completion 2025-11
  Other conditions: Functional Dyspepsia
  View official trial listing →
• Status unknown NCT NCT03056274

  Metformin in Intrahepatic Cholestasis of Pregnancy

  Not yet reported, Not yet reported Epsom and St Helier University Hospitals NHS Trust 40 participants Est. completion 2019-09
  Other conditions: Intrahepatic Cholestases, Pregnancy Complications
  View official trial listing →
• Terminated NCT NCT03092765

  Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

  Not yet reported EA Pharma Co., Ltd. 29 participants Est. completion 2018-10-22 46 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT03124108

  Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

  Not yet reported Genfit 45 participants Est. completion 2018-10-31 24 sites
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Completed NCT NCT03188146

  Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid

  Humanity and Health Research Centre 57 participants Est. completion 2025-02-15 1 site
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Terminated NCT NCT03201952

  Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

  Not yet reported Vanderbilt University Medical Center 2 participants Est. completion 2020-05-01 1 site
  Other conditions: Glucose Intolerance, Gastric Bypass Surgery
  View official trial listing →
• Completed NCT NCT03226067

  Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

  Not yet reported Calliditas Therapeutics AB 111 participants Est. completion 2019-04-11 61 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT03247101

  Probiotics for Gallstones in Post-bariatric Surgery Patients：A Prospective Randomized Trial

  Not yet reported Min-Sheng General Hospital 180 participants Est. completion 2017-12 1 site
  Other conditions: Clostridium Butyricum Miyairi, Gallstones, Gastrointestinal Quality of Life Index
  View official trial listing →
• Completed NCT NCT03266146

  36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

  Not yet reported, Not yet reported Beijing 302 Hospital 90 participants Est. completion 2023-01-31 1 site Stand-alone
  Other conditions: Drug-induced Liver Injury,Chronic
  View official trial listing →
• Completed NCT NCT03322943

  The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital

  West China Hospital 300 participants Est. completion 2018-12-30 1 site
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Status unknown NCT NCT03345589

  A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

  Not yet reported West China Hospital 40 participants Est. completion 2019-01-01 1 site
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT03394924

  A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

  Not yet reported Enanta Pharmaceuticals, Inc 68 participants Est. completion 2020-01-16 86 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT03431896

  Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

  The Cleveland Clinic 37 participants Est. completion 2026-03-09 1 site
  Other conditions: Amyloidosis, Amyloid, Amyloid Neuropathies, Familial, Amyloid Cardiomyopathy, Amyloid - Primary, Transthyretin Amyloidosis, AL Amyloidosis
  View official trial listing →
• Terminated NCT NCT03462940

  Effects of TUDCA on Endothelial Function in Type 2 DM

  Not yet reported Boston University 2 participants Est. completion 2021-02-09 1 site Stand-alone
  Type 2 diabetes Other conditions: Insulin Response, Endothelial Dysfunction
  View official trial listing →
• Terminated NCT NCT03476993

  Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis

  Not yet reported Biocad 9 participants Est. completion 2019-07-01 3 sites Stand-alone
  Other conditions: Liver Cirrhosis, Biliary
  View official trial listing →
• Completed NCT NCT03489889

  Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine

  Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2018-06 1 site Stand-alone
  Other conditions: Ursodeoxycholic Acid, Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT03512808

  A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

  Not yet reported Daewoong Pharmaceutical Co. LTD. 77 participants Est. completion 2017-07-31 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03512821

  A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

  Not yet reported Daewoong Pharmaceutical Co. LTD. 77 participants Est. completion 2017-11-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT03516006

  Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis

  Not yet reported, Not yet reported Fuzhou General Hospital 20 participants Est. completion 2024-01 Stand-alone
  Other conditions: Primary Sclerosing Cholangitis
  View official trial listing →
• Status unknown NCT NCT03521297

  Probiotics in PBC Patients of Poor Response to UDCA

  Not yet reported Sun Yat-sen University 60 participants Est. completion 2021-08-31 1 site
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Status unknown NCT NCT03578055

  BDD With UDCA Therapy After Laparoscopic Cholecystectomy

  Not yet reported Ewha Womans University Mokdong Hospital 172 participants Est. completion 2019-12-31 1 site
  Other conditions: Cholecystitis, Acute, Cholecystitis, Chronic
  View official trial listing →
• Completed NCT NCT03586674

  Fibrates in Pediatric Cholestasis

  Not yet reported Hoda A. Atta 50 participants Est. completion 2018-06-20 2 sites
  Other conditions: Chronic Cholestasis
  View official trial listing →
• Completed NCT NCT03602560

  ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

  Not yet reported Gilead Sciences 265 participants Est. completion 2020-02-16 156 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Terminated NCT NCT03602976

  Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis

  Not yet reported Ethan Weinberg 7 participants Est. completion 2022-01-12 1 site Stand-alone
  Other conditions: Hepatic Sarcoidosis, Elevated Alkaline Phosphatase
  View official trial listing →
• Completed NCT NCT03659058

  Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR

  Not yet reported Zagazig University 400 participants Est. completion 2018-08-01
  Other conditions: Fibrosis, Liver
  View official trial listing →
• Completed NCT NCT03664596

  Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

  Not yet reported Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan 80 participants Est. completion 2020-12-01 1 site
  Other conditions: Non-alcoholic Steatohepatitis
  View official trial listing →
• Completed NCT NCT03665519

  Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis

  Not yet reported National Scientific Medical Center, Kazakhstan 40 participants Est. completion 2020-12-01 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Withdrawn NCT NCT03678480

  A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)

  Not yet reported HighTide Therapeutics (Hong Kong) Limited Est. completion 2021-11-04
  Other conditions: Primary Sclerosing Cholangitis, Cholangitis, Cholangitis, Sclerosing, Bile Duct Diseases, Biliary Tract Diseases, Digestive System Diseases, Adolescent
  View official trial listing →
• Terminated NCT NCT03724175

  The Role of Secondary Bile Acids in Intestinal Inflammation

  Not yet reported, Not yet reported Stanford University 2 participants Est. completion 2026-03-02 1 site Stand-alone
  Other conditions: Ulcerative Colitis, Pouchitis
  View official trial listing →
• Completed NCT NCT03840005

  Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study

  Not yet reported Sheffield Teaching Hospitals NHS Foundation Trust 31 participants Est. completion 2021-05-13 2 sites Stand-alone
  Other conditions: Parkinson's Disease
  View official trial listing →
• Completed NCT NCT03844100

  Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients

  Not yet reported, Not yet reported Gangnam Severance Hospital 37 participants Est. completion 2021-08-04 6 sites
  Other conditions: Dyspepsia, Biliary Dysplasia
  View official trial listing →
• Completed NCT NCT03954327

  Combination Antiretroviral Therapy (cART) for PBC

  Not yet reported University of Alberta 37 participants Est. completion 2024-01-01 6 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Status unknown NCT NCT04076527

  Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis

  University of Leipzig 1200 participants Est. completion 2024-03 50 sites
  Other conditions: PBC, Primary Biliary Cholangitis
  View official trial listing →
• Status unknown NCT NCT04281082

  Genetic Polymorphisms of ABCB11 and ABCB4 in Women With Intrahepatic Cholestasis of Pregnancy (ICP) and in Their First Degree Relatives

  Alexandra Hospital, Athens, Greece 50 participants Est. completion 2022-01-31 1 site
  Other conditions: Cholestasis of Pregnancy
  View official trial listing →
• Status unknown NCT NCT04309773

  Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

  Not yet reported Assistance Publique - Hôpitaux de Paris 104 participants Est. completion 2025-03 1 site
  Other conditions: Primary Sclerosing Cholangitis, Cholestasis
  View official trial listing →
• Status unknown NCT NCT04376528

  Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

  Not yet reported West China Hospital 89 participants Est. completion 2021-12-30 1 site Stand-alone
  Other conditions: Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression
  View official trial listing →
• Terminated NCT NCT04407650

  Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus

  Not yet reported King's College London 55 participants Est. completion 2025-05-29 1 site Stand-alone
  Other conditions: Gestational Diabetes
  View official trial listing →
• Completed NCT NCT04484870

  Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis

  Not yet reported First People's Hospital of Hangzhou 150 participants Est. completion 2019-07-20 1 site
  Other conditions: Choledocholithiasis, Recurrence
  View official trial listing →
• Active, not recruiting NCT NCT04526665

  Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

  Not yet reported Ipsen 161 participants Est. completion 2028-12-01 115 sites
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Withdrawn NCT NCT04531878

  BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases

  Not yet reported, Not yet reported Children's Hospital of Fudan University Est. completion 2023-02-08
  Other conditions: Hereditary Diseases, Cholestasis, Intrahepatic
  View official trial listing →
• Status unknown NCT NCT04542473

  Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children

  Not yet reported, Not yet reported University of Oxford 400 participants Est. completion 2024-06-30 4 sites
  Other conditions: SEPSIS, MALNUTRITION, CHILD
  View official trial listing →
• Terminated NCT NCT04594694

  Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC

  Not yet reported Intercept Pharmaceuticals 75 participants Est. completion 2025-10-14 33 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Status unknown NCT NCT04617561

  Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

  Not yet reported West China Hospital 90 participants Est. completion 2022-11-01 1 site Stand-alone
  Other conditions: Hepatitis, Autoimmune, Primary Biliary Cholangitis
  View official trial listing →
• Status unknown NCT NCT04618575

  Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

  Not yet reported West China Hospital 137 participants Est. completion 2022-11-05 1 site Stand-alone
  Other conditions: Hepatitis, Primary Biliary Cholangitis, Autoimmune
  View official trial listing →
• Completed NCT NCT04620733

  RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

  Not yet reported Gilead Sciences 193 participants Est. completion 2023-08-11 134 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Suspended NCT NCT04711863

  Fluvoxamine for Adults With Mild to Moderate COVID-19

  Not yet reported Asan Medical Center 400 participants Est. completion 2021-07-31 1 site
  Other conditions: Severe Acute Respiratory Syndrome Coronavirus 2, Coronavirus Infection, Mild to Moderate COVID-19
  View official trial listing →
• Status unknown NCT NCT04751188

  A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis

  Not yet reported Instituto Mexicano del Seguro Social 11 participants Est. completion 2021-07 1 site Stand-alone
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Status unknown NCT NCT04786795

  MITE in the Treatment of Dyspepsia After Cholecystectomy

  Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 990 participants Est. completion 2022-02
  Other conditions: Patients With Dyspeptic Symptoms After Cholecystectomy
  View official trial listing →
• Status unknown NCT NCT04810156

  Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis

  Not yet reported Inge Marie Svane 60 participants Est. completion 2025-11-07 5 sites
  Other conditions: Hepatitis, Drug-Induced
  View official trial listing →
• Completed NCT NCT04834557

  Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

  Not yet reported Tanta University 90 participants Est. completion 2022-09-30 1 site Stand-alone
  Other conditions: Rheumatoid Arthritis
  View official trial listing →
• Completed NCT NCT04910178

  Follow-up of NAFLD Patients With MRI-PDFF

  Not yet reported Asmaa Abdelfattah Elsayed 80 participants Est. completion 2021-12-30 1 site Stand-alone
  MASLD Other conditions: Diabetes Type 2
  View official trial listing →
• Status unknown NCT NCT04937023

  Ursodeoxycholic Acid (Udca) as a Local Drug Delivery Agent in the Treatment of Intra-bony Defects

  Not yet reported SVS Institute of Dental Sciences 26 participants Est. completion 2022-12-30 1 site Stand-alone
  Other conditions: Bone Regeneration
  View official trial listing →
• Status unknown NCT NCT04956328

  Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

  Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 120 participants Est. completion 2023-09-20 1 site
  Other conditions: Primary Biliary Cirrhosis
  View official trial listing →
• Completed NCT NCT04977661

  Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

  Not yet reported Kafrelsheikh University 102 participants Est. completion 2021-01-10 1 site
  MASH
  View official trial listing →
• Status unknown NCT NCT05043194

  Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis

  Not yet reported Wei Liu 80 participants Est. completion 2022-07-30 1 site Stand-alone
  Other conditions: Cholestasis of Parenteral Nutrition
  View official trial listing →
• Active, not recruiting NCT NCT05256979

  Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation

  General University Hospital, Prague 20 participants Est. completion 2026-11-30 1 site
  Other conditions: Non-Alcoholic Fatty Liver Disease
  View official trial listing →
• Completed NCT NCT05410535

  To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

  Not yet reported Daewoong Pharmaceutical Co. LTD. 431 participants Est. completion 2022-10-28 1 site
  Other conditions: Gastric Cancer
  View official trial listing →
• Status unknown NCT NCT05416580

  Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes

  Not yet reported University of Banja Luka 60 participants Est. completion 2024-04 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT05467553

  A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection

  Not yet reported National Taiwan University Hospital 30 participants Est. completion 2025-08-31 2 sites Stand-alone
  Other conditions: Hepatitis D
  View official trial listing →
• Status unknown NCT NCT05500937

  Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin

  Not yet reported, Not yet reported First Affiliated Hospital Xi'an Jiaotong University 1000 participants Est. completion 2024-12-31 1 site
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Terminated NCT NCT05526807

  Ursodeoxycholic Acid in C. Difficile Infection

  Not yet reported Nottingham University Hospitals NHS Trust 6 participants Est. completion 2023-12-31 1 site Stand-alone
  Other conditions: Clostridioides Difficile Infection
  View official trial listing →
• Completed NCT NCT05659654

  The Application of Ursodeoxycholic Acid for the Prevention of SARS-CoV-2 Infection (COVID-19)

  Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 95 participants Est. completion 2023-03-08 1 site Stand-alone
  Other conditions: COVID-19
  View official trial listing →
• Completed NCT NCT05685888

  Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation

  First Affiliated Hospital Xi'an Jiaotong University 2000 participants Est. completion 2023-01-05
  Other conditions: Organ Transplantation, COVID-19
  View official trial listing →
• Completed NCT NCT05690646

  Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery

  Not yet reported China National Center for Cardiovascular Diseases 491 participants Est. completion 2024-08-01 1 site Stand-alone
  Other conditions: Cardiac Surgery
  View official trial listing →
• Status unknown NCT NCT05812612

  UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease

  Beijing Ditan Hospital 2000 participants Est. completion 2023-12-30 1 site
  Other conditions: COVID-19 Infection
  View official trial listing →
• Completed NCT NCT05832697

  An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

  Not yet reported Daewoong Pharmaceutical Co. LTD. 44 participants Est. completion 2023-01-30 1 site
  Other conditions: Healthy Subject
  View official trial listing →
• Status unknown NCT NCT05849558

  Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients

  Not yet reported MinaPharm Pharmaceuticals 297 participants Est. completion 2023-12-31 1 site
  Other conditions: Chronic Liver Disease
  View official trial listing →
• Status unknown NCT NCT05902468

  Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus

  Not yet reported, Not yet reported Tanta University 88 participants Est. completion 2024-11-28 2 sites
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT05904067

  A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation

  Not yet reported Institute of Hematology & Blood Diseases Hospital, China 72 participants Est. completion 2025-01-01 1 site
  Other conditions: COVID-19, Hematopoietic Stem Cell Transplantation
  View official trial listing →
• Completed NCT NCT05973370

  Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

  Not yet reported Tanta University 60 participants Est. completion 2024-05-30 1 site
  Other conditions: Rheumatoid Arthritis
  View official trial listing →
• Completed NCT NCT06026865

  S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

  Not yet reported Medical University of Warsaw 60 participants Est. completion 2026-01-01 1 site Stand-alone
  Other conditions: Primary Sclerosing Cholangitis (PSC)
  View official trial listing →
• Completed NCT NCT06060665

  Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

  Not yet reported Gilead Sciences 96 participants Est. completion 2026-05-06 45 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT06091787

  Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy

  Not yet reported Institute of Liver and Biliary Sciences, India 90 participants Est. completion 2024-11-30 1 site Stand-alone
  Other conditions: Liver Regeneration, Ursodeoxycholic Acid, Partial Liver Resection
  View official trial listing →
• Completed NCT NCT06127355

  Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation

  Not yet reported Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 113 participants Est. completion 2022-05-10 1 site Stand-alone
  Other conditions: Gestational Diabetes
  View official trial listing →
• Active, not recruiting NCT NCT06174402

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

  Not yet reported, Not yet reported Han Ying 184 participants Est. completion 2026-12-31 12 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT06247735

  Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

  Not yet reported Kowa Research Institute, Inc. 46 participants Est. completion 2026-07-23 38 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Active, not recruiting NCT NCT06278090

  Impact of Ursodeoxycholic Acid Treatment on the Gallbladder Polyp Evolution

  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 36 participants Est. completion 2027-07 1 site
  Other conditions: Gallbladder Polyp
  View official trial listing →
• Status unknown NCT NCT06287931

  Probiotics for Gallstones in Post-bariatric Surgery Patients

  Not yet reported Shandong Linglong Yingcheng Hospital 400 participants Est. completion 2025-06-01 1 site Stand-alone
  Other conditions: Bariatric Surgery Candidate, Gallstone, Gallstone Attack, Gastrointestinal Quality of Life Index, Probiotics
  View official trial listing →
• Completed NCT NCT06309589

  The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis

  Not yet reported Yilihamu·Abilitifu 60 participants Est. completion 2023-12-31 1 site
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT06350890

  Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

  Not yet reported Shenzhen HighTide Biopharmaceutical Ltd. 408 participants Est. completion 2025-08-04 56 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT06353347

  Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

  Not yet reported Shenzhen HighTide Biopharmaceutical Ltd. 551 participants Est. completion 2025-07-30 64 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT06383403

  A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

  Not yet reported Ipsen 92 participants Est. completion 2026-06-16 60 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT06411275

  A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

  Not yet reported Shenzhen HighTide Biopharmaceutical Ltd. 113 participants Est. completion 2023-01-17 14 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT06415773

  Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

  Not yet reported Shenzhen HighTide Biopharmaceutical Ltd. 367 participants Est. completion 2025-07-25 53 sites
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT06488911

  To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

  Not yet reported Intercept Pharmaceuticals 62 participants Est. completion 2025-10-21 51 sites
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Completed NCT NCT06517862

  Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

  Not yet reported Amira Adel Fouly 140 participants Est. completion 2026-05-01 1 site Stand-alone
  Other conditions: Neonatal Hyperbilirubinemia
  View official trial listing →
• Completed NCT NCT06591455

  A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

  Not yet reported Han Ying 30 participants Est. completion 2025-08-18 1 site
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Enrolling by invitation NCT NCT06591468

  A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics

  Not yet reported, Not yet reported Han Ying 244 participants Est. completion 2027-12-31 2 sites
  Other conditions: Primary Biliary Cholangitis (PBC)
  View official trial listing →
• Not yet recruiting NCT NCT06629909

  Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial

  Not yet reported Baermed 54 participants Est. completion 2026-10-31 1 site
  Other conditions: Liver Cirrhosis
  View official trial listing →
• Completed NCT NCT06715319

  Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis

  Not yet reported Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 100 participants Est. completion 2024-04-29 1 site
  Other conditions: PBC
  View official trial listing →
• Not yet recruiting NCT NCT06842472

  PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

  Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70 participants Est. completion 2029-12 Stand-alone
  Other conditions: Breast Cancer
  View official trial listing →
• Not yet recruiting NCT NCT06884748

  Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

  Not yet reported Medical College of Wisconsin 30 participants Est. completion 2028-05-01 1 site
  Other conditions: Clostridioides Difficile Infection
  View official trial listing →
• Active, not recruiting NCT NCT06918080

  Hepatoprotective Measures for Children at High Risk of NAFLD

  Not yet reported Ain Shams University 200 participants Est. completion 2025-07 2 sites Stand-alone
  MASLD Other conditions: Obesity and Overweight, Acute Lymphoblastic Leukemia
  View official trial listing →
• Completed NCT NCT07072949

  The Impact of Ursodeoxycholic Acid and Probiotics on Metabolic Outcomes in Type 2 Diabetic Patients Taking Metformin

  Not yet reported University of Banja Luka 90 participants Est. completion 2024-01-31 1 site
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT07102979

  Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response

  Not yet reported Chang Gung Memorial Hospital 19 participants Est. completion 2025-12-31 1 site Stand-alone
  Other conditions: Liver Fibrosis
  View official trial listing →
• Not yet recruiting NCT NCT07122206

  Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

  Methodist Health System 100 participants Est. completion 2027-08
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Not yet recruiting NCT NCT07273734

  UDCA to Prevent Post-TIPS Hepatic Encephalopathy

  Not yet reported West China Hospital 270 participants Est. completion 2027-12-31 1 site Stand-alone
  Other conditions: Hepatic Encephalopathy (HE), TIPS
  View official trial listing →
• Withdrawn NCT NCT07457632

  Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.

  Not yet reported University of Alabama at Birmingham Est. completion 2028-12-31
  Other conditions: Diabetic Macular Edema (DME)
  View official trial listing →
• Not yet recruiting NCT NCT07477782

  Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation

  Not yet reported Assistance Publique - Hôpitaux de Paris 72 participants Est. completion 2030-05 1 site
  Other conditions: Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)
  View official trial listing →
• Not yet recruiting NCT NCT07525401

  Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis

  Not yet reported Combined Military Hospital, Pakistan 88 participants Est. completion 2026-10 Stand-alone
  Other conditions: Hepatitis A, Hepatitis E Virus Infection
  View official trial listing →
• Not yet recruiting NCT NCT07664020

  Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.

  Not yet reported Institute of Liver and Biliary Sciences, India 130 participants Est. completion 2027-11-01 1 site Stand-alone
  Other conditions: Chronic Liver Disease
  View official trial listing →
• Not yet recruiting NCT NCT07756710

  Ursodeoxycholic Acid in Barrett's Endotherapy

  Columbia University 15 participants Est. completion 2027-11 1 site
  Other conditions: Barrett's Esophagus With Dysplasia
  View official trial listing →
• Not yet recruiting NCT NCT07795151

  Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis

  Not yet reported, Not yet reported Beijing 302 Hospital 68 participants Est. completion 2030-08-31 1 site
  Other conditions: Primary Biliary Cholangitis
  View official trial listing →
• Not yet recruiting NCT NCT07852780

  Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis

  Not yet reported, Not yet reported Tanta University 80 participants Est. completion 2027-10-01
  Other conditions: Sepsis
  View official trial listing →
• Completed NCT NCT07867366

  Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy

  Not yet reported Muhammad Aamir Latif 220 participants Est. completion 2026-07-31 1 site Stand-alone
  Other conditions: Hyperbilirubinemia Indirect
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT04407650

No related coverage yet.